MPA-MIA Community Webinar Series 2026
2026-07-14 - 2026-07-28 | Tasmania
Join us for an informative series of three live webinars for patients with melanoma and their carers.
Hosted by Melanoma Patients Australia (MPA) and Melanoma Institute Australia (MIA), each week our free webinar will provide you with a rare opportunity to hear from medical experts and community members as they focus on a different topic of interest each week. The webinar will conclude with a Q&A panel discussion.
The webinars are held every Tuesday evening for three weeks. Please click on the registration link below for each webinar that you’d like to attend.
Note that the webinars are held from 7pm to 8pm AEST.
Cost: Free
Webinar One: ‘Your melanoma nurse: What they do and how they help’
When: Tuesday 14 July | 7 – 8pm AEST
Speakers:

Rebecca Johnson – National Melanoma Nurses Program Manager
Peta Holly – Specialist Melanoma Telehealth Nurse
A community member

REGISTERWebinar Two: ‘Understanding endocrine side effects of immunotherapy’
When: Tuesday 21 July | 7 – 8pm AEST
Speakers:

Dr Stephanie Zunder – Medical Oncologist
Dr Annabel Hayes – Endocrinologist
Aled Gaynor – Medical Oncology Clinical Nurse Consultant
A community member

REGISTERWebinar Three: ‘Understanding sentinel lymph node biopsies: Helping you decide’
When: Tuesday 21 July | 7 – 8pm AEST
Speakers:

A/Prof Alexander van Akkooi – Surgical Oncologist
Shahn Coburn – Surgical Clinical Nurse Consultant
A community member

REGISTER

MOGA Annual Scientific Meeting
2026-08-05 - 2026-08-07 | RACV Royal Pines Resort, Ross Street, Gold Coast, Queensland, 4217, Australia
The 2026 MOGA Annual Scientific Meeting (ASM) will bring together Australian medical oncologists to reflect on a timely theme:
Reimagining Cancer Care: Is Less Doing More?
In recent years, oncology has found itself at a fascinating crossroads. With ever-deepening insights into tumour biology, immunotherapy, molecular profiling, and patient-centred care, we are beginning to ask a powerful and, at times, uncomfortable question: Are we sometimes doing too much?
We are now confronting the possibility that treatment de-escalation is not just a compromise, but potentially a pathway to more humane, precise, and effective care. This conversation extends well beyond protocols and guidelines. It challenges us to think deeply about patient autonomy, shared decision-making, and what quality of life truly means in the era of personalised medicine.
This ASM will bridge disciplines and perspectives—from surgical oncology to medical and radiation oncology, to palliative care and psychosocial support. We will consider not only clinical evidence, but also the ethical, logistical, and emotional dimensions of doing less. We will look at emerging biomarkers and novel drug targets that allow us to fine-tune therapy like never before. Exploring what it means to personalise care in the truest sense—not just through science, but through listening.
Location: RACV Royal Pines, Gold Coast, Australia
Key Dates:
Early Bird Registrations Close: 14 June 2026
Abstract Submissions Close: 14 June 2026
Abstract Selection Advice: 3 July 2026
Abstract Acceptance by Presenter: 10 July 2026
Travel Award Applications Open: 3 July 2026
Travel Award Applications Close: 10 July 2026
Travel Award Recipient Notification: 17 July 2026
FIND OUT MORE

MRFF Genomics Health Futures
2026-08-19 17:00 (Australia/Sydney) | Tasmania
The objective of this grant opportunity is to provide grants of financial assistance to support medical research and medical innovation projects that:
Stream 1 (TCR): develop genomic tools and technologies to identify genetic predisposition to cancer and improve screening and targeted intervention. Focus on increased access to genomic testing and on liquid biopsy.
Stream 2 (TCR): conduct scalable research to enhance novel gene discoveries, increase diagnostic rates and enable disease modelling to support development of targeted therapies or prevention strategies.
Stream 3 (Incubator): develop novel methods for using polygenic risk scores to identify subgroups of the population at high risk of common and complex diseases (cardiovascular disease, diabetes and other common and/or complex diseases).
Stream 4 (Incubator): develop novel methods for improving accuracy and usefulness of polygenic risk scores to stratify people with common cancers for surveillance and treatment (breast cancer, colorectal cancer, prostate cancer and other common cancers)
Stream 5 (TCR): undertake research to enhance or streamline uptake of clinical genomics into practice.
Stream 6 (Accelerator): develop and maintain infrastructure to support research collaboration by enabling data sharing, portability, longevity and connectivity of analysis across Australia. Research conducted should address emerging ethical, legal and social issues associated with the governance of clinical and genomic datasets with particular focus on the application of advanced analytics (e.g. AI) to enhance the diagnostic utility of genomics.
Applicants must propose research that addresses these objectives and those of the Genomics Health Futures Mission as outlined in the Roadmap and Implementation Plan.
Key Dates

Minimum data due date: 22 July 2026
Applications close: 19 August 2026
Indicative funding status: Funding anticipated to be awarded from June 2027
SEE GRANT GUIDELINESSEE WEBSITE

2026 TCS Sydney Marathon presented by ASICS
2026-08-30 | Tasmania
Whether you’re chasing your debut or your next star, the TCS Sydney Marathon presented by ASICS is your moment to shine.
Sydney is the bucket-list race that redefines what’s possible, so come experience the place where the world comes to finish.
When you nominate MIA as your charity of choice, funds raised support our life-saving melanoma research, so we can reach our mission of zero deaths from melanoma.
Make sure you set up your fundraising page, as well as registering for the event – both can be done at the link below.
REGISTER NOW

European Congress of Pathology
2026-09-12 - 2026-09-16 | Stockholmsmässan, Mässvägen 1, Älvsjö, 12530, Sweden
The European Society of Pathology (ESP) and the Swedish Society of Pathology are delighted to invite you to the 38th European Congress of Pathology (ECP 2026), to be held at Stockholmsmässan, from 12 –16 September 2026, in the heart of Sweden’s capital.
ECP 2026 will bring together more than 5,000 participants from all over the world—pathologists, clinicians, researchers, molecular biologists, bioinformaticians, medical scientists, and industry partners. The meeting will provide an ideal opportunity for professional development, networking, to exchange insights, and will demonstrate the commitment of the ESP to contributing to Pathology progress in the near future.
The motto of the congress – “Innovation Driving Excellence in Pathology” –acknowledges the significant improvement that pathology innovation has brought and continues to bring to diagnostics, assessment of prognosis and therapy response prediction and clinical practice. The excellent programme prepared by the ESP working groups, ESP-affiliated societies, education and trainee committees, and other collaborating societies will include keynote lectures, slide seminars, symposia, and interactive workshops, from internationally renowned speakers and leaders in their fields. There will be a special focus on digital pathology, AI integration, and emerging technologies that are transforming our field.
Location: Stockholmsmässan, Stockholm, Sweden
Key Dates:
Abstract submission deadline: 8 April 2026
Abstract notifications: early June 2026
Registration and payment deadline for authors of accepted abstracts: 25 June 2026
FIND OUT MORE

ABNA Annual Conference
2026-09-16 - 2026-09-18 | Crowne Plaza Hobart, 110 Liverpool Street, Hobart, Tasmania, 7000, Australia
ABNA’s Annual Conference “From Collection to Discovery: Enabling Research, Accelerating Impact” will be held in Hobart, 16-18 September 2026.
The star event in the annual ABNA calendar, this meeting provides an opportunity to connect with biobankers and biospecimen scientists from around the world to discuss shared strategies to shape the future of biobanking. The 2026 program will once again foster professional growth and encourage a commitment to excellence through expert talks exploring novel approaches to traditional biospecimen science as well as and cutting-edge biobanking technology.
Enjoy workshops, special interest group meetings, rapid fire presentations, poster displays, and elevator pitch presentations as well as a range of networking events including biobanker speed networking, a site visit and gala dinner to facilitate collaborations with researchers, policymakers, corporate sponsors and industry leaders to drive innovation and partnership.
Don’t miss this chance to engage with the Australasian Biobanking community in the stunning city of Hobart – home to a thriving research and education sector. See you there!
Location: Crown Plaza Hobart, Tasmania
Key Dates:
Abstract submission deadline: 14 August 2026
Abstract notifications: late August/early September 2026
Early bird registration deadline: 31 July 2026
FIND OUT MORE

IAP Congress
2026-10-08 - 2026-10-13 | Fukuoka International Congress Center, 2-1 Sekijōmachi, Fukuoka, 8120032, Japan
It is with great pleasure that we welcome you to the 2026 XXXVI Congress of the International Academy of Pathology in Fukuoka, bringing together the most enthusiastic and dedicated scholars in the field of pathology. Our goal is to create a unique platform where the latest advancements, challenges, and debates in diagnostic and molecular pathology are shared and discussed.
This biennial international congress on pathology will be held jointly with the 72nd Autumn Annual Meeting of the Japanese Society of Pathology, which is held annually in Japan.
As the theme of this year’s congress is “Vision for the Future”, we would like to hold a joint session in the sense of a new challenge that is not bound by the conventional format for the continued development of IAP. Key topics in molecular pathology including spatial transcriptome analysis and artificial intelligence will be explored across various subspecialties, reflecting the evolving landscape of our field. We will also provide the programs on basic issues in pathology such as the educational system and infectious diseases.
Location: Fukuoka International Congress Center, Fukuoka Sunpalace, Fukuoka, Japan
Key Dates:
Abstract Submission Deadline: Friday 10 April 2026, 17:00 (JST)
Young Pathologist Award Application & Abstract Submission: Friday 10 April 2026, 17:00 (JST)
IAP Bursary Abstract Submission: Friday 10 April 2026, 17:00 (JST)
IAP Bursary Application Deadline: Thursday 30 April 2026
Notification of Acceptance: June 2026
FIND OUT MORE

ESMO Congress
2026-10-23 - 2026-10-27 | IFEMA Madrid, Avda. Del Partenon, 5, Madrid, 28042, Spain
The ESMO Congress is a highly influential global oncology meeting for clinicians, researchers, patient advocates, journalists and healthcare industry representatives from all over the world.
ESMO 2026 will be a platform for breakthroughs in oncology research, clinical practice and patient care. Participants can expect impactful new data, interactive education, excellent networking opportunities and an innovative exhibition area. By attending the ESMO Congress 2026, oncologists will not only gain insights into the latest developments but also play an active role in shaping the future of oncology on a global scale.
A comprehensive educational and scientific programme will foster the exchange and debate of translational cancer science, highlight the first announcements of potentially practice-changing data, and stimulate multidisciplinary discussions aimed at improving treatment options for patients.
Learning objectives:

To stay informed about current approaches in cancer prevention, screening, and early detection
To gain insights into the latest advances in basic, translational, and clinical cancer research
To explore the clinical implications of scientific breakthroughs in cancer biology, diagnostics, and treatment
To be updated on state-of-the-art therapeutic strategies for patients with cancer
To examine the emerging role of artificial intelligence in cancer diagnosis, research and therapy

Location: IFEMA Madrid, Madrid, Spain
Key Dates:
Early Registration Deadline: 22 July 2026 at 23:59 CEST
Abstract Submission Deadline: 12 May 2026 at 21:00 CEST
Late-Breaking Abstract Submission Deadline: 8 September 2026 at 21:00 CEST
Conference Dates: 23 October 2026 – 27 October 2026
FIND OUT MORE

ESSO Congress
2026-11-04 - 2026-11-06 | IFEMA Madrid, Avda. Del Partenon, 5, Madrid, 28042, Spain
The Annual Congress of the European Society of Surgical Oncology (ESSO) is the leading event in Europe dedicated to advancing surgical cancer care.
Bringing together oncology surgeons, researchers, and healthcare professionals from across the globe, the ESSO Congress offers a dynamic platform for sharing cutting-edge research, surgical innovations, and multidisciplinary approaches to cancer treatment.
With a strong focus on education, collaboration, and excellence in patient outcomes, the congress fosters dialogue, drives progress, and shapes the future of surgical oncology.
With the theme Surgical Oncology without Borders: Innovations and Challenges Worldwide, we will explore the latest advancements, global perspectives, and shared challenges that shape the future of Surgical Oncology around the world.
Location: IFEMA Madrid, Spain
Key Dates:
Abstract submission deadline: 6 May 2026
Abstract review results: 6 July 2026
Early registration deadline: 19 August 2026
FIND OUT MORE

SITC Annual Meeting
2026-11-04 - 2026-11-08 | Phoenix Convention Center, 100 N 3rd Street, Phoenix, AZ, United States
SITC 2026 is the premier international conference focused on cancer immunotherapy, bringing together leaders from academia, regulatory agencies, government, and industry for education, scientific exchange, and networking.
The conference provides a multidisciplinary educational and interactive environment focused on improving outcomes for cancer patients by incorporating strategies based on basic and applied cancer immunotherapy.
Why attend SITC 2026?

Cutting-edge sessions by IO experts (Don’t miss over 40 sessions on the latest IO research)
In-person networking opportunities with IO luminaries
Access the latest immuno-oncology research

Location: Phoenix Convention Center, Phoenix, Arizona, United States
Key Dates:
Regular and early career investigator award abstract submission deadline: 25 June 2026
Abstract notifications: 31 July 2026
Late-breaking abstract submission deadline: 10 September 2026
Abstract notifications: 28 September 2026
FIND OUT MORE

COSA Annual Scientific Meeting
2026-11-11 - 2026-11-13 | ICC Sydney and Cockle Bay – Darling Harbour, 14 Darling Dr, Sydney, NSW, 2000, Australia
We are honoured to co-convene the 2026 COSA Annual Scientific Meeting (ASM) to be held at the International Convention Centre (ICC) Sydney from Wednesday 11 to Friday 13 November 2026, with pre-conference workshops being held on Tuesday 10 November.
The theme for the 2026 COSA ASM is The precision generation: From cancer prevention to personalised care.

This theme reflects how far cancer care has evolved; from a one-size-fits-all rigid approach, to care that is increasingly tailored to the individual, across the entire cancer journey.
The disease theme will have a strong focus on lung cancers, alongside sessions addressing head and neck cancers, early-onset cancers such as colorectal cancer, and brain cancer, including both primary and metastatic disease. As always, equity will be embedded throughout the program, reflecting COSA’s ongoing commitment to improving outcomes for all people affected by cancer.
It has been almost a decade since the COSA ASM was held in Sydney, so we are excited to bring it back to showcase the remarkable advances that have transformed cancer care over this time, including the molecular biomarker realm and the evolution of novel transformative therapeutics.
Australia has developed deep expertise across clinical care, research and clinical trials, implementation and policy, and the program will highlight this local leadership alongside contributions from international experts in the fields of drug development, precision oncology, pharmacogenomics and palliative and supportive care.

Location: International Convention Centre (ICC), Sydney, Australia
Key Dates:
Delegate Designed Symposia Submissions Close: 3 July 2026
Abstract Submissions Close: 7 August 2026
Abstract Decision Notification: 2 September 2026
Abstract Acceptance by Presenter: 11 September 2026
Early Bird Registration Deadline: 11 September 2026
Pre-conference Workshops: 10 November 2026
FIND OUT MORE

NHMRC Partnership Projects
2026-11-11 17:00 | Tasmania
The Partnership Project funding scheme provides funding and support to create new opportunities for researchers and policy makers to work together to define research questions, undertake research, interpret the findings and implement the findings into policy and practice.

Partnership Projects create partnerships among decision makers, policy makers, managers, clinicians and researchers and answer a specific research question to influence health and wellbeing through changes in the delivery, organisation, funding and access to health services.
Partnership Projects will support collaborations, within the Australian context, that translate research evidence into health policy and health practice, to improve health services and processes.
The objectives of the Partnership Project scheme are to:
• Meet the need for more effective integration of research evidence into health policy and service delivery
• Create partnerships among policy makers, managers, service providers and researchers
• Provide support to answer often complex and difficult questions that policy makers, managers and service providers face when making decisions and implementing policies that affect Australians’ health and health care
• Be highly responsive to the priorities of government, the community and health professionals
• Enable applicants to apply for funding at any time during the year to allow researchers and Partner Organisations to develop timely collaborations.

Key Dates for Peer Review Cycle 2:
Applications open: 19 March 2026
NHMRC-approved Administering Institutions waiver due: 8 July 2026
Minimum data due: 22 July 2026
Applications close: 5 August 2026
Peer review meetings: 17-19 November 2026
Key Dates for Peer Review Cycle 3:
Applications open: 23 July 2026
NHMRC-approved Administering Institutions waiver due: 14 October 2026
Minimum data due: 28 October 2026
Applications close: 11 November 2026
Peer review meetings: 2-4 March 2027
SEE GRANT GUIDELINESSEE WEBSITE

Australasian Melanoma Conference
2026-11-19 - 2026-11-21 | Sofitel Melbourne on Collins, 25 Collins Street, Melbourne, Victoria, 3000, Australia
The Australasian Melanoma Conference 2026 is a premier event for professionals involved in melanoma and skin cancer research, diagnosis, and clinical management. The conference will present new discoveries from basic science and explore cutting-edge paradigms in melanoma and skin cancer care. It is designed for clinicians, researchers, and healthcare professionals seeking the latest updates in the field and opportunities for networking and collaboration.
The AMC 2026 conference program will feature a broad range of speakers across multi disciplines and concurrent sessions under the key categories of:

Prevention
Early Detection
Advanced Diseases
Survivorship

Location: Sofitel Melbourne on Collins, Melbourne, Australia
Key Dates:
Conference Dates: 19 November 2026 – 21 November 2026
Early Bird Registration Deadline: 31 July 2026
Abstract Submission Deadline: 17 April 2026 at 11:59 PM (AEST)
FIND OUT MORE
